67 results
Page 3 of 4
DFAN14A
bi49omnddks jfz
30 Mar 22
Additional proxy materials by non-management
10:21am
DEFA14A
v35glcs0kxfjy15zn0
28 Mar 22
Additional proxy soliciting materials
5:31pm
PREC14A
2r09v11tpo7en0x03j7
25 Mar 22
Preliminary proxy with contested solicitation
5:15pm
8-K
EX-99.1
0vg9qb knl6v8f9i
21 Mar 22
Athira Pharma Announces Appointment of Dr. Michael A. Panzara to its Board of Directors
7:21am
8-K
6t1idlm pi
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
8-K
EX-99.1
8bda6feozk7o 8dfdql
21 Oct 21
Departure of Directors or Certain Officers
4:09pm
8-K
EX-99.1
i9vej ijew2iz7
16 Aug 21
Athira Pharma Reports Second Quarter 2021 Financial Results and Business Update
4:11pm
8-K
k7ko3 1d8140b
9 Aug 21
Other Events
6:06am
8-K
EX-99.1
oxpz77n1n0vw6
9 Aug 21
Other Events
6:06am
8-K
EX-99.1
qniy914 dp516dz
17 Jun 21
Departure of Directors or Certain Officers
9:32pm
DEF 14A
xpis6gruh5qxrfh47c
16 Apr 21
Definitive proxy
6:02am
10-K
xh4zn8lmht8a
25 Mar 21
Annual report
12:00am
424B4
9il15gvc5ras6dq a3v
21 Jan 21
Prospectus supplement with pricing info
12:00am
DRS
tie3kjle6izeqj4
6 Jan 21
Draft registration statement
12:00am
10-Q
by4 vao5g
12 Nov 20
Quarterly report
4:16pm